Ulrike Gnad-Vogt
Hoofd Techniek/Wetenschap/O&O bij CureVac SE
Actieve functies van Ulrike Gnad-Vogt
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Hoofd Techniek/Wetenschap/O&O | 01-01-2011 | - |
Loopbaan van Ulrike Gnad-Vogt
Eerdere bekende functies van Ulrike Gnad-Vogt
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CUREVAC N.V. | Hoofd Techniek/Wetenschap/O&O | 01-01-2011 | 01-01-2019 |
| Corporate Officer/Principal | 01-01-2019 | - |
Opleiding van Ulrike Gnad-Vogt
| Universität des Saarlandes | Doctorate Degree |
Statistieken
Internationaal
| Duitsland | 4 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CUREVAC N.V. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
- Beurs
- Insiders
- Ulrike Gnad-Vogt
- Ervaring
